Insider · CIK 0001319763

El Coronado Holdings, LLC

CIK 0001319763 Name as filed on the most recent filing

Filed as El Coronado Holdings, LLC (179)

341 transaction lines · from 179 filings · filed 2005-03-04 to 2014-02-13 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2012-01-27 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 17,720, acquired Open Form 4 filing 0000945621-12-000030
2012-01-23 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 192,000, acquired Open Form 4 filing 0000945621-12-000017
2011-10-17 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 9,177, acquired Open Form 4 filing 0000945621-11-000199
2011-06-14 S, Open-market sale Chelsea Therapeutics International, Ltd.CHTP 2 lines 97,818, disposed Open Form 4 filing 0000894579-11-000198
2011-06-13 S, Open-market sale Chelsea Therapeutics International, Ltd.CHTP 227,777, disposed Open Form 4 filing 0000894579-11-000198
2010-06-09 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 296,790, acquired Open Form 4 filing 0000945621-10-000105
2010-06-04 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 31,900, acquired Open Form 4 filing 0000945621-10-000103
2010-06-03 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 2 lines 33,309, acquired Open Form 4 filing 0000894579-10-000093
2010-05-28 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 16,497, acquired Open Form 4 filing 0000894579-10-000093
2010-04-09 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 21,401, acquired Open Form 4 filing 0000945621-10-000089
2010-04-08 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 3,608, acquired Open Form 4 filing 0000945621-10-000085
2010-04-07 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 9,672, acquired Open Form 4 filing 0000945621-10-000085
2010-03-18 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 3 lines 50,562, acquired Open Form 4 filing 0000945621-10-000076
2010-03-01 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 8,250, acquired Open Form 4 filing 0000945621-10-000060
2010-01-25 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 2 lines 58,681, acquired Open Form 4 filing 0000943663-10-000013
2010-01-22 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 5,344, acquired Open Form 4 filing 0000943663-10-000013
2010-01-21 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 145,832, acquired Open Form 4 filing 0000943663-10-000009
2010-01-20 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 144,840, acquired Open Form 4 filing 0000943663-10-000009
2010-01-15 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 32,713, acquired Open Form 4 filing 0000943663-10-000004
2010-01-05 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 64,704, acquired Open Form 4 filing 0000945621-10-000006
2009-12-31 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 89,661, acquired Open Form 4 filing 0000945621-10-000002
2009-12-30 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 64,994, acquired Open Form 4 filing 0000945621-09-000096
2009-12-29 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 62,992, acquired Open Form 4 filing 0000945621-09-000096
2009-12-18 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 43,946, acquired Open Form 4 filing 0000945621-09-000092
2009-12-17 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 66,177, acquired Open Form 4 filing 0000945621-09-000092
2009-12-15 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 101,664, acquired Open Form 4 filing 0000945621-09-000090
2009-11-12 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 2 lines 105,818, acquired Open Form 4 filing 0000943663-09-000220
2009-11-11 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 21,810, acquired Open Form 4 filing 0000943663-09-000214
2009-11-10 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 14,625, acquired Open Form 4 filing 0000943663-09-000214
2009-11-06 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 2 lines 228,060, acquired Open Form 4 filing 0000943663-09-000212
2009-11-05 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 3 lines 53,695, acquired Open Form 4 filing 0000943663-09-000210
2009-11-04 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 5,675, acquired Open Form 4 filing 0000943663-09-000210
2009-10-23 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 172,584, acquired Open Form 4 filing 0000943663-09-000206
2009-10-20 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 135,227, acquired Open Form 4 filing 0000943663-09-000200
2009-10-19 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 48,620, acquired Open Form 4 filing 0000943663-09-000200
2009-10-12 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 182,232, acquired Open Form 4 filing 0000943663-09-000196
2009-10-09 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 60,305, acquired Open Form 4 filing 0000943663-09-000196
2009-10-08 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 109,257, acquired Open Form 4 filing 0000943663-09-000196
2009-10-07 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 127,085, acquired Open Form 4 filing 0000943663-09-000194
2009-10-06 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 78,859, acquired Open Form 4 filing 0000943663-09-000194
2009-10-01 P, Open-market purchase Chelsea Therapeutics International, Ltd.CHTP 72,939, acquired Open Form 4 filing 0000943663-09-000192

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. El Coronado Holdings, LLC, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001319763

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.